Today, I am excited to announce that I co-founded the biotech company Sirius NeoSight together with my scientific co-founders Arnaud Vigneron and David Gueyrard and my co-founding partners Jean-Guillaume Lafay and Stephane Legastelois.

Sirius NeoSight exploits a breakthrough technology from leading French institutions (CNRS, Université Claude Bernard Lyon 1, Inserm, INSA Lyon – Institut National des Sciences Appliquées de Lyon, CPE Lyon, Centre Régional Léon Bérard, Hospices Civils de Lyon – HCL) aiming at revolutionizing the detection of subclinical neo-cancers, early relapses and at guiding therapeutic decisions.

After about a year of hard work as an entrepreneur in residence within PULSALYS, several awards (Bourse French Tech Emergence and the deeptech label from Bpifrance), I will now lead the company as the CEO.
I would like to thank Arnaud and David for the great science and the hard work on preparing the launch of the company, as well as Jean-Guillaume and Stéphane for their trust in our project, their help in shaping the business strategy and for joining the founding team of Sirius.

I now look forward to working with the team as we have great challenges ahead of us. Together we will build and grow the company, advance the program to unleash the full potential of our technology, with the aim to create a successful biotech company!